SCHEMBL7822690

SCHEMBL7822690

CCn1c(=O)c(NC(=O)C2CCCC2)c(N)n2nc(COCc3ccc(OC)cc3)nc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.38
LMNA P02545 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 2/20 0.38
TSHR P16473 2/20 0.38
TP53 P04637 2/20 0.38
HTT P42858 2/20 0.38
HPGD P15428 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
JAK2 O60674 2/20 0.37
IKBKB O14920 1/20 0.37
RIPK2 O43353 1/20 0.37
LCK P06239 1/20 0.37
JAK1 P23458 1/20 0.37
TYK2 P29597 1/20 0.37
SYK P43405 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7003073 0.80 PDE1B (0.36) LMNAPOLBTP53MEN1KMT2A
SCHEMBL7003301 0.77 ADORA2A (0.35) LMNASMN1; SMN2TP53HTTMEN1
SCHEMBL7662109 0.73 ADORA1 (0.48) LMNATSHRMEN1KMT2AADORA3
SCHEMBL8567698 0.71 ADORA1 (0.48) LMNATSHRMEN1KMT2AADORA3
SCHEMBL7671571 0.70 TLR7 (0.45) LMNANPC1RAB9ASMN1; SMN2POLB
SCHEMBL7668666 0.70 POLB (0.47) LMNANPC1RAB9ASMN1; SMN2POLB
SCHEMBL8575326 0.67 TSHR (0.49) P2RX7LMNANPC1RAB9ASMN1; SMN2
SCHEMBL8577964 0.65 KDM4E (0.43) P2RX7NPC1RAB9ASMN1; SMN2POLB
SCHEMBL7666412 0.63 ADORA1 (0.51) LMNATSHRMEN1KMT2AADORA3
SCHEMBL7095767 0.62 HSP90AA1 (0.37) P2RX7LMNANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087973-A1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY Boehringer Ingelheim Pharma KG (DE) 2001-04-04 EP disclosed
WO-1999065912-A1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-12-23 WO disclosed